AVEO PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - March 11, 2011

Attached files

file filename
10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC.d10k.htm
EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC.dex108.htm
EX-10.19 - CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT - AVEO PHARMACEUTICALS, INC.dex1019.htm
EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.dex322.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - AVEO PHARMACEUTICALS, INC.dex211.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex311.htm
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.dex321.htm
EX-10.30 - COLLABORATION AND LICENSE AGREEMENT - AVEO PHARMACEUTICALS, INC.dex1030.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-165530) pertaining to the 2002 Stock Incentive Plan, 2010 Stock Incentive Plan, and 2010 Employee Stock Purchase Plan of AVEO Pharmaceuticals, Inc. of our report dated March 11, 2011, with respect to the consolidated financial statements of AVEO Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

/S/    ERNST & YOUNG LLP

March 11, 2011

AVEO PHARMACEUTICALS, INC. Reports